Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Industry News

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

May 17, 2018

News Industry News

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

January 05, 2016

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Industry News

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 01, 2015

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Kona Medical Initiates Clinical Trial of Non-Invasive Therapy for Resistant Hypertension

August 27, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

January 08, 2014

News Industry News

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

December 16, 2013

News Industry News

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Industry News

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

October 28, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

September 02, 2013

News Industry News

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

June 04, 2013

Advertisement

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

Boston Scientific Announces Scheduled Presentations At TCT 2015

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Kona Medical Initiates Clinical Trial of Non-Invasive Therapy for Resistant Hypertension

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Boston Scientific Announces Schedule Of Major Presentations At Transcatheter Cardiovascular Therapeutics 2013

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content